Wells Fargo raises Amphastar Pharmaceuticals target price to $25 from $20
AMPH•Wells Fargo raised its target price for Amphastar Pharmaceuticals to $25 from $20.
Related News
BD: Citigroup raises target price to $241 from $208
BDX•
Wells Fargo cuts PDF Solutions target price to $39 from $50
PDFS•
Brookdale forecasts 2026 adjusted EBITDA of $495 million to $502 million
BKD•
Utz Brands Q3 sales miss estimates on inflation, weaker demand
UTZ•
Affirm Holdings price objective raised to $109 from $104 by BofA Global Research
AFRM•